Back to Explorer

Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices, Direct Marking, and Global Unique Device Identification Database Requirements for Certain Devices: Guidance for Industry and Food and Drug Administration Staff

FinalCenter for Biologics Evaluation and Research Center for Devices and Radiological Health07/25/2022

Description

FDA has updated this guidance to include FDA’s compliance policy regarding Global Unique Device Identification Database (GUDID) submission requirements for certain class I devices considered consumer health products. Specifically, FDA does not intend to enforce the GUDID submission requirements under 21 CFR 830.300 for class I devices considered to be consumer health products that are required to bear a UDI on their labels and device packages. Additionally, FDA does not intend to enforce the GUDID submission requirements under 21 CFR 830.300 for class I and unclassified devices, other than implantable, life-supporting, or life-sustaining (I/LS/LS) devices, regardless of whether they are consumer health products, before December 8, 2022 (an additional 75 calendar days).

Scope & Applicability

Product Classes

10
Class I Device

Low risk medical devices

Unclassified Device

Compliance dates and policies for unclassified devices; pre-amendments device type for which a classification regulation has not been promulgated

Class III Device

Generally recommended for Enhanced Documentation; Regulatory classification mentioned for implantable sensors and HPV tests; Mentioned in the context of an in vitro nucleic acid test for CMV DNA.

Class II Device

Devices subject to section 522 postmarket surveillance orders; devices subject to postmarket surveillance orders

I/LS/LS Device

Implantable, life-supporting, or life-sustaining devices

Unclassified Devices

Subject to UDI compliance date policies

Consumer Health Products

510(k)-exempt class I devices sold directly to consumers over-the-counter

Class I Reserved Devices

Class I devices not exempt from 510(k) notification; devices for which information is available on FDA website

Restricted Devices

devices restricted to sale, distribution, or use upon authorization

Implantable device

Telephone follow-up after surgery

Stakeholders

2
Labeler

Person who causes a label to be applied or modified; The entity responsible for submitting information to GUDID.; Entity responsible for identifying device constituent parts

healthcare professionals

Use of local healthcare professionals (HCPs) and facilities.

Regulatory Context

Attributes

1
Non-Sterile

Condition for devices manufactured and labeled prior to compliance dates

Related CFR Sections (10)

Related Warning Letters (4)

  • CGMP/QSR/Medical Devices/Adulterated

    LEVO AG

    2025-10-21
  • CGMP/QSR/Medical Devices/Adulterated

    NeuroSync, Inc.

    2025-05-20
  • CGMP/QSR/Medical Devices/Adulterated/Misbranded

    Argon Medical Productions & Vertrieb Gesellschaft MBH & CO

    2024-10-29
  • CGMP/QSR/Medical Devices/Misbranded

    Wello Inc.

    2023-11-14

See Also (8)